Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7%
Eton Pharmaceuticals Q4 GAAP EPS of $0.05 missed the $0.20 estimate by 75%, though revenue of $21.3M topped consensus and surged 82.9% year-over-year.
5 articles, transcripts, and reports
Eton Pharmaceuticals Q4 GAAP EPS of $0.05 missed the $0.20 estimate by 75%, though revenue of $21.3M topped consensus and surged 82.9% year-over-year.
Eton Pharmaceuticals Inc (NASDAQ: ETON) Q4 2021 Earnings Conference
Eton Pharmaceuticals Inc (NASDAQ: ETON) Q2 2021 Earnings Conference
Eton Pharmaceuticals, inc (NASDAQ: ETON) Q1 2021 Earnings Conference
Eton Pharmaceuticals, inc (NASDAQ: ETON) Q4 2020 Earnings Conference